Equities

Chengdu Olymvax Biopharmaceuticals Inc

688319:SHH

Chengdu Olymvax Biopharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)8.38
  • Today's Change-0.03 / -0.36%
  • Shares traded694.32k
  • 1 Year change-52.09%
  • Beta--
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue496547487
OPERATING EXPENSES
Cost of revenue total374328
Selling, general and admin. expenses, total335361303
Depreciation/amortization161411
Unusual expense(income)0.15(0.25)0.05
Other operating expenses, total(0.31)(22)(2.63)
Total operating expense493506386
Operating income3.1042102
Other, net132.035.61
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1644107
Provision for income taxes4.1817(0.77)
Net income after taxes1127108
Minority interest6.110--
Net income before extra. Items1827108
Total extraordinary items------
Net income1827108
Inc.avail. to common excl. extra. Items1827108
Inc.avail. to common incl. extra. Items1827108
EPS RECONCILIATION
Basic/primary weighted average shares405405385
Basic/primary eps excl. extra items0.040.070.28
Basic/primary eps incl. extra items0.040.070.28
Dilution adjustment------
Diluted weighted average shares405405385
Diluted eps excl. extra items0.040.070.28
Diluted eps incl. extra items0.040.070.28
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.0400
Gross dividend - common stock1500
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental7.185.071.30
SUPPLEMENTAL INCOME
Depreciation, supplemental302522
Total special items0.15(0.25)0.05
NORMALISED INCOME
Normalized income before taxes1643107
Effect of special items on income taxes0.04(0.1)0.02
Income tax excluding impact of special items4.2217(0.76)
Normalized income after tax1226108
Normalized income avail. to common1826108
Basic normalized EPS0.040.070.28
Diluted normalized EPS0.040.070.28
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.